C WorldWide Group’s Viking Therapeutics VKTX Stock Holding History

C WorldWide Group’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-232,138	Closed	-$2.31M	–	108
2019 Q1	$2.31M	Hold	232,138	–	–	0.03%	89
2018 Q4	$1.78M	Buy	+232,138	New	+$2.78M	0.03%	84

Other funds holding VKTX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C WorldWide Group's VKTX Position: Q2 2019 in Review

C WorldWide Group sold out of Viking Therapeutics (VKTX) in Q2 2019, closing a stake of 232,138 shares — an estimated $2.31M sold.

C WorldWide Group first reported a position in VKTX in Q4 2018 and held it in 2 quarters. The position peaked at $2.31M in Q1 2019. 156 funds tracked by Wall St. Rank hold VKTX as of Q2 2019.

C WorldWide Group reported no remaining Viking Therapeutics position as of Q2 2019 after selling out during the quarter.
C WorldWide Group sold 232,138 Viking Therapeutics shares in Q2 2019, an estimated $2.31M.
C WorldWide Group first reported a position in Viking Therapeutics in Q4 2018 and held it in 2 quarters.
C WorldWide Group's Viking Therapeutics position peaked at $2.31M in Q1 2019.
156 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.